CEO Interview: Kyojin Park of Avomed

CEO Interview: Kyojin Park of Avomed

Korea’s Only Drug Developer with a Proven Track Record of Revenue Stability

Korea’s Only Drug Developer with a Proven Track Record of Revenue Stability

Sep 20, 2024

This video marks the first episode of Laplace Partners’ interview series, featuring Kyojin Park, founder of Arbormed and an expert in drug licensing.

In this interview, we discuss Arbormed’s innovative business model and its Wilson’s disease treatment project, while also gaining insights into CEO Park’s hiring philosophy and the key factors behind biotech startup success.

We hope this video provides a deeper understanding of Arbormed’s vision and goals. Stay tuned, and we appreciate your support! 😊

Back to News

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners